| For: | Lee SW, Peng YC, Lien HC, Ko CW, Tung CF, Chang CS. Clinical values of Barcelona Clinic Liver Cancer subgroup and up-to-7 criteria in intermediate stage hepatocellular carcinoma with transcatheter arterial chemoembolization. World J Clin Cases 2022; 10(21): 7275-7284 [PMID: 36157996 DOI: 10.12998/wjcc.v10.i21.7275] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i21/7275.htm |
| Number | Citing Articles |
| 1 |
Chao Ma, Yan Wang, Yan-Hua Bai, Feng Duan, Mao-Qiang Wang. Transarterial chemoembolization with prophylactic right inferior phrenic artery embolization for hepatocellular carcinoma in segments VII and VIII. Abdominal Radiology 2026; 51(9) doi: 10.1007/s00261-025-05366-0
|
| 2 |
Mi Fan, Tingting Niu, Binwei Lin, Feng Gao, Bangxian Tan, Xiaobo Du. Prognostic value of preoperative serum ferritin in hepatocellular carcinoma patients undergoing transarterial chemoembolization. Molecular and Clinical Oncology 2024; 20(3) doi: 10.3892/mco.2024.2720
|
| 3 |
Nur Şener, Abdullah Yakupoğlu. Yttrium-90 transarterial radioembolization and capecitabine in hepatocellular carcinoma with portal vein involvement. Medicine 2023; 102(35) doi: 10.1097/MD.0000000000034674
|
| 4 |
Shiying Yang, Xuelei Yao, Yali Ren, Teng Ding, Jiamin Gao, Lin Shentu. Advances in assessment systems and non-pharmacological intervention strategies for cancer-related fatigue following transarterial chemoembolization in hepatocellular carcinoma: a narrative review. Supportive Care in Cancer 2026; 34(11) doi: 10.1007/s00520-026-11380-9
|